## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 1.2% below STRENGTH zone (4.0-10.0%); PEG 2.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($145.96)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Lam Research Corporation (LRCX): A Bull Case Theory**
- Source: Finviz | 20251204T141800 | Somewhat-Bullish | Relevance: 100%
- This article summarizes a bull thesis on Lam Research Corporation (LRCX), a leading semiconductor equipment company. Although the stock has appreciated significantly in 2025, the analyst maintains a Hold rating with an accumulation recommendation below $110, viewing Lam as a long-term compounder. The company's strong financial performance, leadership in etch and deposition tools, and robust future growth prospects are highlighted.

**2. Stocks making big moves yesterday: Lam Research, Sweetgreen, Applied Materials, Lattice Semiconductor, and The Pennant Group**
- Source: Finviz | 20251203T080000 | Bullish | Relevance: 100%
- This article details the significant stock movements of five companies on Tuesday: Lam Research, Sweetgreen, Applied Materials, Lattice Semiconductor, and The Pennant Group. Each company experienced a rise in stock value due to various positive developments, including analyst upgrades, raised price targets, expansion news, and strong "Buy" ratings. The report highlights the specific catalysts behind each company's stock appreciation.

**3. Wall Street Bulls Look Optimistic About Lam Research (LRCX): Should You Buy?**
- Source: Finviz | 20251204T170804 | Somewhat-Bullish | Relevance: 100%
- Wall Street analysts are optimistic about Lam Research (LRCX), with an average brokerage recommendation (ABR) of 1.69, suggesting a strong buy. However, the article advises against relying solely on ABR due to potential positive bias from brokerage firms and instead recommends using the Zacks Rank, which indicates a Zacks Rank #2 (Buy) for LRCX due to recent positive earnings estimate revisions.

**4. M&T Bank Corp Sells 8,300 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251204T120914 | Somewhat-Bullish | Relevance: 100%
- M&T Bank Corp reduced its stake in Lam Research Corporation by 7.7% in Q2, selling 8,300 shares and now owning 100,150 shares valued at approximately $9.75 million. Institutional investors hold 84.61% of LRCX, while insiders recently sold over 102,608 shares. Analysts maintain a "Moderate Buy" rating with an average price target of $152.87 for Lam Research.

**5. Lam Research Corporation $LRCX Shares Sold by Beacon Pointe Advisors LLC**
- Source: MarketBeat | 20251204T085710 | Somewhat-Bullish | Relevance: 100%
- Beacon Pointe Advisors LLC reduced its stake in Lam Research Corporation by 8.3% in the second quarter, holding 70,239 shares valued at $6.84 million. Other hedge funds also adjusted their positions, and 84.61% of Lam Research stock is owned by institutional investors. The article further details Lam Research's stock performance, recent earnings, dividend announcement, and analyst ratings, alongside insider selling activity by the CFO and a Director.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |
| 2025-11-25 | UBS | $175 | $165 | +6% |
| 2025-11-12 | Citigroup | $190 | $175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | UBS | main | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($2.00M) |
| Sells | 6 ($14.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $15M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Momentum building: MRS_20 improving +1.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.20 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($14.5M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $224.6B |
| Beta | 1.78 |
| 52W Range | $56.32 - $179.80 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.20 |
| Forward P/E | 28.2 |
| Current P/E | 32.8 |
| YoY Growth | 16.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -0.6% to 1.2% (+1.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.8pp (needs >4.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. AM_20 at 3.5% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.19% (CS: 63) | Neutral |
| RSI_14 | 56.7 | Neutral |
| MACD Histogram | 0.44 | Bullish |
| vs SMA20 | 1.033x | Above |
| vs SMA50 | 1.062x | Above |
| vs SMA200 | 1.521x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $158.70
- **Stop Loss:** $145.96 (8.0% risk)
- **Target:** $171.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 78
- **Position Value:** $12,378.60
- **Portfolio %:** 12.38%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*